Stockscreener 앱 받기
28.18
1.66%
0.46
시간 외 거래:
28.18
전일 마감가:
$27.72
열려 있는:
$27.91
하루 거래량:
151.23K
Relative Volume:
1.38
시가총액:
$408.20M
수익:
$1.80M
순이익/손실:
$1.76B
주가수익비율:
0.2375
EPS:
118.674
순현금흐름:
$-149.23M
1주 성능:
-0.07%
1개월 성능:
+34.61%
6개월 성능:
+105.84%
1년 성능:
+75.69%
1일 변동 폭
$27.21
$28.73
1주일 범위
$27.01
$28.73
52주 변동 폭
$10.80
$28.73
인히브릭스 Stock (INBX) Company Profile
명칭
Inhibrx Biosciences Inc
전화
(858) 795-4220
주소
11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA
INBX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INBX
Inhibrx Biosciences Inc
|
28.18 | 401.54M | 1.80M | 1.76B | -149.23M | 118.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
인히브릭스 Stock (INBX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-23 | 개시 | JMP Securities | Mkt Perform |
| 2024-01-23 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2022-03-16 | 개시 | SMBC Nikko | Outperform |
| 2021-09-21 | 개시 | JMP Securities | Mkt Outperform |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2020-09-14 | 개시 | Credit Suisse | Outperform |
| 2020-09-14 | 개시 | Evercore ISI | Outperform |
모두보기
인히브릭스 주식(INBX)의 최신 뉴스
Using portfolio simulators with Inhibrx Biosciences Inc. included2025 Pullback Review & AI Driven Price Forecasts - Newser
Can Inhibrx Biosciences Inc. rally from current levels2025 Momentum Check & Reliable Intraday Trade Plans - Newser
Inhibrx Biosciences Inc. stock chart pattern explained2025 Major Catalysts & Fast Entry and Exit Trade Plans - Newser
Statistical indicators supporting Inhibrx Biosciences Inc.’s strength2025 Price Momentum & Advanced Technical Signal Analysis - Newser
Full technical analysis of Inhibrx Biosciences Inc. stockQuarterly Trade Review & AI Driven Stock Movement Reports - Newser
Using Bollinger Bands to evaluate Inhibrx Biosciences Inc.Quarterly Profit Summary & High Win Rate Trade Tips - Newser
Will Inhibrx Biosciences Inc. stock go up soonPortfolio Value Report & AI Enhanced Trading Alerts - Newser
Can Inhibrx Biosciences Inc. recover in the next quarter2025 Price Momentum & Risk Controlled Daily Trade Plans - Newser
Does Inhibrx Biosciences Inc. show high probability of reboundPortfolio Growth Summary & High Conviction Buy Zone Picks - Newser
What is the long term forecast for Inhibrx Biosciences Inc. stockGap Down & Weekly High Return Stock Opportunities - خودرو بانک
Sentiment analysis tools applied to Inhibrx Biosciences Inc.Portfolio Return Report & Safe Entry Zone Identification - Newser
Is Inhibrx Biosciences Inc. a cyclical or defensive stockWeekly Trade Review & Low Drawdown Investment Ideas - خودرو بانک
Sector ETF performance correlation with Inhibrx Biosciences Inc.Bull Run & Low Drawdown Trading Strategies - Newser
Ranking Inhibrx Biosciences Inc. among high performing stocks via toolsWeekly Profit Recap & Verified Trade Idea Suggestions - Newser
Is Inhibrx Biosciences Inc. forming a bullish divergence2025 Key Lessons & Daily Price Action Insights - خودرو بانک
Is Inhibrx Biosciences Inc. forming a breakout patternMarket Trend Report & Weekly Return Optimization Alerts - خودرو بانک
Is Inhibrx Biosciences Inc. still worth holding after the dipPortfolio Performance Summary & Smart Money Movement Tracker - Newser
What the charts say about Inhibrx Biosciences Inc. todayQuarterly Trade Summary & Free Safe Entry Trade Signal Reports - Newser
Inhibrx Biosciences Inc. stock outlook for YEAR2025 Price Momentum & Reliable Trade Execution Plans - Newser
Analyzing drawdowns of Inhibrx Biosciences Inc. with statistical toolsWeekly Stock Analysis & Daily Price Action Insights - Newser
Visualizing Inhibrx Biosciences Inc. stock with heatmapsEarnings Recap Summary & Proven Capital Preservation Methods - Newser
Is it too late to sell Inhibrx Biosciences Inc.Entry Point & Entry Point Confirmation Alerts - Newser
Top chart patterns to watch in Inhibrx Biosciences Inc.July 2025 Trade Ideas & Daily Chart Pattern Signal Reports - Newser
Stock Market Recap: Will Inhibrx Biosciences Inc. outperform small cap indexesPortfolio Performance Report & Accurate Entry and Exit Point Alerts - خودرو بانک
What candlestick patterns are forming on Inhibrx Biosciences Inc.Global Markets & AI Forecast for Swing Trade Picks - Newser
Key resistance and support levels for Inhibrx Biosciences Inc.2025 Technical Overview & Fast Momentum Stock Entry Tips - Newser
Predicting Inhibrx Biosciences Inc. trend using moving averages2025 Market Sentiment & Real-Time Stock Price Movement Reports - Newser
Can Inhibrx Biosciences Inc. outperform in the next rallyWeekly Market Outlook & Verified Short-Term Plans - خودرو بانک
Inhibrx Biosciences Inc. stock prediction for this weekDollar Strength & Fast Moving Stock Trade Plans - Newser
Will Inhibrx Biosciences Inc. price bounce be sustainableQuarterly Profit Report & Expert Approved Momentum Trade Ideas - Newser
Real time breakdown of Inhibrx Biosciences Inc. stock performance2025 Market Sentiment & Growth Focused Investment Plans - Newser
Comparing Inhibrx Biosciences Inc. in custom built stock radarsIPO Watch & High Return Stock Watch Alerts - Newser
Inhibrx Biosciences Inc. stock trendline breakdown2025 Valuation Update & Daily Chart Pattern Signal Reports - Newser
Is Inhibrx Biosciences Inc. in a consolidation phaseCEO Change & AI Driven Stock Price Forecasts - خودرو بانک
Is Inhibrx Biosciences Inc. affected by consumer sentimentSell Signal & High Accuracy Swing Entry Alerts - خودرو بانک
Is This the Dip to Buy in Inhibrx Biosciences Inc. getLinesFromResByArray error: size == 0 - 강소기업뉴스
Gainers Report: Is Inhibrx Biosciences Inc. stock forming a triangle pattern2025 Support & Resistance & AI Powered Buy/Sell Recommendations - خودرو بانک
인히브릭스 (INBX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):